PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29173042-0	2018	Antithrombin conformational modulation by D-myo-inositol 3,4,5,6-tetrakisphosphate (TMI), a novel scaffold for the development of antithrombotic agents.	4-tolyl isocyanate	84-87	serpin family C member 1	Homo sapiens	0-12	
29173042-3	2018	Recently, a new compound, named TMI, was discovered in our group with nanomolar affinity to antithrombin, and shown to be able to induce a partial activation of antithrombin.	4-tolyl isocyanate	32-35	serpin family C member 1	Homo sapiens	92-104	
29173042-3	2018	Recently, a new compound, named TMI, was discovered in our group with nanomolar affinity to antithrombin, and shown to be able to induce a partial activation of antithrombin.	4-tolyl isocyanate	32-35	serpin family C member 1	Homo sapiens	161-173	
22742452-3	2012	We screened a large database in silico to find alternative molecules and predicted d-myo-inositol 3,4,5,6-tetrakisphosphate (TMI) to strongly interact with antithrombin.	4-tolyl isocyanate	125-128	serpin family C member 1	Homo sapiens	156-168	
22742452-5	2012	Functional studies, fluorescence analysis, and citrullination experiments revealed that TMI induced a partial activation of antithrombin that facilitated the interaction with heparin and low affinity heparins.	4-tolyl isocyanate	88-91	serpin family C member 1	Homo sapiens	124-136	
22742452-6	2012	TMI improved antithrombin inhibitory function of plasma from homozygous patients with antithrombin deficiency with a heparin binding defect and also in a model with endothelial cells.	4-tolyl isocyanate	0-3	serpin family C member 1	Homo sapiens	13-25	
22742452-6	2012	TMI improved antithrombin inhibitory function of plasma from homozygous patients with antithrombin deficiency with a heparin binding defect and also in a model with endothelial cells.	4-tolyl isocyanate	0-3	serpin family C member 1	Homo sapiens	86-98